Topic: point-of-care diagnostics
The $4.4 million award sets Talis up to work on a molecular diagnostic capable of detecting the bacteria in patient samples within 20 minutes.
Mammoth Biosciences is developing a CRISPR-based platform to detect any biomarker containing DNA or RNA.
The deal will give Axcel a portfolio of in vitro diagnostics and point-of-care testing systems that generated sales of $66 million last year.
Biosensorix's new collaboration will give it access to an electrochemical lateral flow immunosensor.
Qiagen will gain control of a pipeline of assay panels designed to diagnose infections affecting the respiratory and gastrointestinal systems.
Mologic received a CE mark for its point-of-care test that rapidly diagnoses bacterial vaginosis.
The latest deal sees Alere agree to sell its Epocal point-of-care blood diagnostic unit to Siemens for an undisclosed sum.
Owlstone Medical and Cancer Research UK have begun a clinical trial designed to identify biomarkers of cancer in breath samples.
Bluejay Diagnostics has entered a clinical research agreement with Hitachi Chemical to create a noninvasive test that detects the antibody IgE in tears.